JP2003529555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003529555A5 JP2003529555A5 JP2001549382A JP2001549382A JP2003529555A5 JP 2003529555 A5 JP2003529555 A5 JP 2003529555A5 JP 2001549382 A JP2001549382 A JP 2001549382A JP 2001549382 A JP2001549382 A JP 2001549382A JP 2003529555 A5 JP2003529555 A5 JP 2003529555A5
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- item
- equivalents
- carried out
- acetic anhydride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19963607.9 | 1999-12-23 | ||
| DE19963607A DE19963607B4 (de) | 1999-12-23 | 1999-12-23 | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
| PCT/EP2000/013027 WO2001047912A1 (de) | 1999-12-23 | 2000-12-20 | Verfahren zur herstellung von 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinonen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003529555A JP2003529555A (ja) | 2003-10-07 |
| JP2003529555A5 true JP2003529555A5 (enExample) | 2008-02-14 |
Family
ID=7934888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001549382A Pending JP2003529555A (ja) | 1999-12-23 | 2000-12-20 | ４−（ヘテロアリール−メチル）−ハロゲン−１（２ｈ）−フタラジノンの製造方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6891041B2 (enExample) |
| EP (1) | EP1242405B1 (enExample) |
| JP (1) | JP2003529555A (enExample) |
| KR (1) | KR100654265B1 (enExample) |
| CN (1) | CN1221545C (enExample) |
| AT (1) | ATE273972T1 (enExample) |
| AU (1) | AU772981B2 (enExample) |
| BG (1) | BG65387B1 (enExample) |
| BR (1) | BR0016634A (enExample) |
| CA (1) | CA2395407C (enExample) |
| CZ (1) | CZ20022146A3 (enExample) |
| DE (2) | DE19963607B4 (enExample) |
| DK (1) | DK1242405T3 (enExample) |
| EE (1) | EE04940B1 (enExample) |
| ES (1) | ES2223626T3 (enExample) |
| HR (1) | HRP20020605B1 (enExample) |
| HU (1) | HUP0300992A3 (enExample) |
| IL (2) | IL150017A0 (enExample) |
| MX (1) | MXPA02006224A (enExample) |
| NO (1) | NO321357B1 (enExample) |
| NZ (1) | NZ519285A (enExample) |
| PL (1) | PL200714B1 (enExample) |
| PT (1) | PT1242405E (enExample) |
| RO (1) | RO121211B1 (enExample) |
| RS (1) | RS50458B (enExample) |
| RU (1) | RU2250900C2 (enExample) |
| SI (1) | SI1242405T1 (enExample) |
| SK (1) | SK285522B6 (enExample) |
| UA (1) | UA72021C2 (enExample) |
| WO (1) | WO2001047912A1 (enExample) |
| ZA (1) | ZA200205853B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| US7151102B2 (en) * | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| GB0419072D0 (en) * | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
| TWI404716B (zh) * | 2006-10-17 | 2013-08-11 | Kudos Pharm Ltd | 酞嗪酮（ｐｈｔｈａｌａｚｉｎｏｎｅ）衍生物 |
| KR101598231B1 (ko) * | 2007-10-17 | 2016-02-26 | 쿠도스 파마슈티칼스 리미티드 | 4-[3-(4-시클로프로판카르보닐-피페라진-1-카르보닐)-4-플루오로-벤질]-2ｈ-프탈라진-1-온 |
| CA2737400C (en) * | 2008-10-07 | 2016-11-22 | Astrazeneca Uk Limited | Pharmaceutical formulation 514 |
| JP6545148B2 (ja) | 2013-03-13 | 2019-07-17 | フラットリー ディスカバリー ラブ，エルエルシー | ピリダジノン化合物及び嚢胞性線維症の治療のための方法 |
| WO2016146303A1 (en) * | 2015-03-19 | 2016-09-22 | Clariant International Ltd | Biodegradable sugar-amide-surfactants for enhanced oil recovery |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE567431A (enExample) * | 1957-05-07 | |||
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| EP0634404A1 (en) * | 1993-07-13 | 1995-01-18 | Rhone Poulenc Agriculture Ltd. | Phtalazin derivatives and their use as pesticides |
| JP3919835B2 (ja) * | 1994-08-09 | 2007-05-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 縮合ピリダジン系化合物 |
| NZ290952A (en) * | 1994-08-09 | 1998-05-27 | Eisai Co Ltd | Phthalazine derivatives optionally substituted in position-1 by (generally benzyl) amino groups |
| RU2128175C1 (ru) * | 1994-08-09 | 1999-03-27 | Эйсай Ко., Лтд. | Конденсированный пиридазин или его фармакологически приемлемая соль, средство, проявляющее ингибирующую активность в отношении циклической гмф- фосфодиэстеразы |
| CA2275686C (en) * | 1996-12-18 | 2006-10-17 | Neurogen Corporation | Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| ITMI981670A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI20000261A1 (it) * | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
-
1999
- 1999-12-23 DE DE19963607A patent/DE19963607B4/de not_active Expired - Fee Related
-
2000
- 2000-12-20 PL PL355525A patent/PL200714B1/pl not_active IP Right Cessation
- 2000-12-20 DK DK00983354T patent/DK1242405T3/da active
- 2000-12-20 DE DE50007520T patent/DE50007520D1/de not_active Expired - Fee Related
- 2000-12-20 BR BR0016634-0A patent/BR0016634A/pt not_active Application Discontinuation
- 2000-12-20 SK SK892-2002A patent/SK285522B6/sk not_active IP Right Cessation
- 2000-12-20 PT PT00983354T patent/PT1242405E/pt unknown
- 2000-12-20 MX MXPA02006224A patent/MXPA02006224A/es active IP Right Grant
- 2000-12-20 CZ CZ20022146A patent/CZ20022146A3/cs unknown
- 2000-12-20 SI SI200030486T patent/SI1242405T1/xx unknown
- 2000-12-20 US US10/168,794 patent/US6891041B2/en not_active Expired - Fee Related
- 2000-12-20 ES ES00983354T patent/ES2223626T3/es not_active Expired - Lifetime
- 2000-12-20 EP EP00983354A patent/EP1242405B1/de not_active Expired - Lifetime
- 2000-12-20 WO PCT/EP2000/013027 patent/WO2001047912A1/de not_active Ceased
- 2000-12-20 UA UA2002076049A patent/UA72021C2/uk unknown
- 2000-12-20 JP JP2001549382A patent/JP2003529555A/ja active Pending
- 2000-12-20 HR HR20020605A patent/HRP20020605B1/xx not_active IP Right Cessation
- 2000-12-20 RS YUP-473/02A patent/RS50458B/sr unknown
- 2000-12-20 RU RU2002119559/04A patent/RU2250900C2/ru not_active IP Right Cessation
- 2000-12-20 AU AU20122/01A patent/AU772981B2/en not_active Ceased
- 2000-12-20 HU HU0300992A patent/HUP0300992A3/hu unknown
- 2000-12-20 CN CNB008175608A patent/CN1221545C/zh not_active Expired - Fee Related
- 2000-12-20 AT AT00983354T patent/ATE273972T1/de not_active IP Right Cessation
- 2000-12-20 EE EEP200200307A patent/EE04940B1/xx not_active IP Right Cessation
- 2000-12-20 RO ROA200200653A patent/RO121211B1/ro unknown
- 2000-12-20 KR KR1020027007997A patent/KR100654265B1/ko not_active Expired - Fee Related
- 2000-12-20 NZ NZ519285A patent/NZ519285A/xx unknown
- 2000-12-20 CA CA002395407A patent/CA2395407C/en not_active Expired - Fee Related
- 2000-12-20 IL IL15001700A patent/IL150017A0/xx active IP Right Grant
-
2002
- 2002-06-04 IL IL150017A patent/IL150017A/en not_active IP Right Cessation
- 2002-06-19 BG BG106843A patent/BG65387B1/bg unknown
- 2002-06-21 NO NO20023014A patent/NO321357B1/no not_active IP Right Cessation
- 2002-07-22 ZA ZA200205853A patent/ZA200205853B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002519061A5 (enExample) | ||
| JP2002506648A5 (enExample) | ||
| JP2004525194A5 (enExample) | ||
| JP2004517472A5 (enExample) | ||
| MXPA02008801A (es) | Derivados de indol, proceso para la preparacion de los mismos y su uso. | |
| JP2003520017A5 (enExample) | ||
| JP2002533216A5 (enExample) | ||
| NO20030341D0 (no) | Skallmetallkatalysator og en forlöper for denne, en fremgangsmåte for fremstilling av disse og anvendelse av katalysatoren | |
| AU2003206311A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
| ZA200300829B (en) | The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands. | |
| JP2001515920A5 (enExample) | ||
| AU2002359161A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
| JP2000507362A5 (enExample) | ||
| JP2002519182A5 (enExample) | ||
| PL366401A1 (en) | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. | |
| JP2007501782A5 (enExample) | ||
| TWD106698S1 (zh) | 個人混合杯 | |
| JP2003529555A5 (enExample) | ||
| JP2003515534A5 (enExample) | ||
| JP2000141643A5 (enExample) | ||
| JP2003524569A5 (enExample) | ||
| PT1689410E (pt) | Prevenção e tratamento de doenças cardíacas hipertensivas pelos estrogénios selectivos 8beta-vinil-estra-1,3,5(10)-trieno-3,17beta-diol e 17beta-fluoro-9alfa-vinil-estra-1,3,5(10)-trieno-3,16alfa-diol | |
| JP2006500410A5 (enExample) | ||
| JP2000319390A5 (enExample) | ||
| HUP0204187A3 (en) | Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram |